STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), ...

Me is teetering on the edge of bankruptcy and actively seeking a buyer. That buyer, unless explicitly restricted, could gain ...

Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data.

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Gene-edited crops in India, including drought-tolerant rice, nutritious bananas, and disease-resistant chilli, are enhancing ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...